Search - tctmd.com

Displaying 121 - 140 of 149

Sort: Relevancy | Date

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Shelley Wood

September 24, 2017

News Daily News

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Michael O'Riordan

June 22, 2017

Presentation TVT 2017

The Imaging Conundrum of Bicuspid Aortic Valve Disease - Almost 50 Shades of Gray!

Presenter: Robert O. Bonow, Martin B. Leon, Nicolo Piazza

June 15, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Shelley Wood

March 24, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

Presentation TCT 2016

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben

November 01, 2016

Presentation TCT 2016

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples)

Presenter: A. Pieter Kappetein, Allan Schwartz, Mathew Williams

October 30, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

Más de 1 de cada 10 Pacientes del Registro norteamericano TAVR Tratados Fuera de indicación

Shelley Wood

November 12, 2015

News Daily News

More Than 1 in 10 Patients in US TAVR Registry Treated Off-Label

Shelley Wood

November 11, 2015

Presentation TCT 2015

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

Presenter: Michael J. Reardon, Torsten P. Vahl, Sung-Han Yoon

October 13, 2015

Presentation TCT 2015

How Did I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Yongjian Wu

October 11, 2015

Presentation TCT 2015

How Would I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Mao Chen

October 11, 2015

Presentation TCT 2015

How Should I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Yongjian Wu

October 11, 2015

News Industry News

Direct Flow Medical, Inc Announces FDA Approval to Broaden SALUS U.S. Pivotal Trial

April 09, 2015

News Daily News

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

April 03, 2015

Presentation TCT 2014

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

Presenter: Graham A. Cassel, Hans R. Figulla, Greg L. Kaluza, Jochen Wöhrle, Peter Boekstegers

September 14, 2014

Advertisement

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

One in 10 TAVR Patients Treated Off-Label: TVT Registry

The Imaging Conundrum of Bicuspid Aortic Valve Disease - Almost 50 Shades of Gray!

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples)

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Más de 1 de cada 10 Pacientes del Registro norteamericano TAVR Tratados Fuera de indicación

More Than 1 in 10 Patients in US TAVR Registry Treated Off-Label

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

How Did I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

How Would I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

How Should I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Direct Flow Medical, Inc Announces FDA Approval to Broaden SALUS U.S. Pivotal Trial

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content